CAVA: Q4 Margin Collapse Exposes the 135x PE Trap
Key Takeaways
- CAVA's Q4 gross margin of 14.9% represents the worst quarter since going public, down sharply from Q2's 20.6%.
- At 134.7x trailing earnings and 25.3x sales, the stock prices in flawless execution that Q4 results contradict.
- Net income fell 81% sequentially from Q1 to Q4, while capex consumed 93% of operating cash flow.
- The salmon menu launch added cost pressure at the wrong time, compressing margins during an already seasonal-weak quarter.
- Avoid CAVA until May 14 earnings clarify whether margin deterioration is a one-quarter blip or a structural trend.
CAVA Group posted Q4 gross margins of 14.9% — down from 20.6% just two quarters earlier. The stock trades at $72.73, a 134x trailing PE, pricing in flawless execution from a fast-casual chain that just delivered its weakest quarter since going public.
The bull case for CAVA has always been simple: Mediterranean food is underpenetrated, same-store sales are strong, and the unit economics will compound as the chain scales. That story held through mid-2025 when gross margins hovered near 20%. It no longer holds at 14.9%.
With an $8.5 billion market cap on $1.18 billion in annual revenue, CAVA needs everything to go right. The Q4 numbers suggest it won't.
Valuation: Premium Pricing for Deteriorating Fundamentals
CAVA trades at 134.7x trailing earnings, 25.3x sales, and 8.9x book value. The EV/EBITDA sits at 291.6x (see how to value a stock) based on Q4's annualized run rate — a number that belongs to a high-growth software company, not a restaurant operator with sub-15% gross margins.
For context, Chipotle — the closest comparable — trades around 50-60x earnings with gross margins consistently above 25%. CAVA's premium demands either significantly faster unit growth or margin expansion. Q4 delivered neither.
The price-to-book ratio of 8.9x means investors are paying nearly $9 for every $1 of equity. When margins compress, that leverage works in reverse.
Q4 Earnings: Revenue Down, Margins Crushed
Q4 revenue came in at $275.0 million, down 17% sequentially from Q1's $331.8 million. Some seasonality is expected in the restaurant business, but the gross profit tell the real story: $41.0 million on a 14.9% margin, compared to $63.3 million at 19.1% in Q1.
Net income collapsed to $4.9 million — an 81% decline from Q1's $25.7 million. Diluted EPS hit $0.04, barely above breakeven. The full-year picture looks better ($63.7 million net income across four quarters), but the trajectory is pointing down.
The salmon menu launch reportedly added 100 basis points of cost pressure. Management positioned this as a strategic investment. The margin impact says otherwise — protein cost inflation in a business with already-thin margins is a structural risk, not a growth initiative.
Balance Sheet: Adequate but Leveraging Up
CAVA carries $466.5 million in total debt against $780.3 million in shareholders' equity — a debt-to-equity ratio of 0.60. Working capital stands at $120.3 million with a current ratio of 1.74, both adequate for ongoing operations.
The concern is capital allocation. Capex consumed 92.9% of operating cash flow in Q4, leaving free cash flow at just $0.02 per share. CAVA is spending aggressively on new unit buildouts while margins deteriorate. In Q2, when margins were healthy, the capex-to-OCF ratio was a more comfortable 68%. The Q4 figure suggests the expansion is outpacing the business's ability to self-fund.
Growth Story: Strong Pipeline, Weakening Returns
Revenue grew 23% year-over-year on a fiscal year basis, driven primarily by new unit openings rather than same-store improvements. The health-focused Mediterranean positioning remains differentiated — Zacks highlighted CAVA's "sustainable edge" from menu innovation and health-conscious branding.
But growth without margin expansion is just burning capital faster. SG&A expenses ran at 11.8% of revenue in Q4, up from 10.8% in Q3. Operating income margin shrank to 3.1% from 8.0% in Q3. The operating leverage story — the core thesis for restaurant scaling — ran in reverse last quarter.
Analyst consensus projects revenue reaching roughly $625-$804 million per quarter by fiscal 2030, implying a $2.8 billion annual run rate. Even if CAVA achieves this, the stock's current $8.5 billion market cap already prices in most of that growth.
Who Should Own CAVA and at What Price
The bull case requires gross margins recovering above 18%, sustained 20%+ unit growth, and no further protein cost surprises. At 134x earnings, there is zero margin of safety if any of these assumptions fail.
Graham number for CAVA sits at just $2.53 per share — the current price is 28x that figure. Even for growth investors comfortable with premium multiples, the risk-reward has shifted. A stock that was compelling at $45 near its 52-week low looks dangerous at $73 with deteriorating margins.
The next earnings report on May 14, 2026 will determine whether Q4 was an anomaly or a trend. Until then, the 135x PE demands perfection the business isn't delivering.
Conclusion
CAVA is a well-run restaurant concept in an attractive category. None of that is in dispute. What's in dispute is whether a 14.9% gross margin quarter deserves a $8.5 billion valuation.
The stock has already pulled back 28% from its $101.50 year high, but it remains expensive by every conventional metric. Revenue growth is real but margin trajectory matters more at this valuation — and margins are compressing. Avoid until Q1 2026 earnings clarify whether the Q4 margin hit was temporary or structural.
Frequently Asked Questions
Sources & References
www.sec.gov
Disclaimer: This content is for informational purposes only and does not constitute financial advice. Consult qualified professionals before making investment decisions.